Business Overview
2016
17
$4M
Seed
1
1
Founded in 2016, POMICELL built a groundbreaking, AI-powered machine learning platform. Taking the human-in-the-loop approach farther, we engage our partners in the process, optimize and personalize the range of analytical tools, and finally make the metadata usable. Using our state-of-the-art proprietary algorithms, methodologies, and data biotech companies can reduce, by up to 80%, the time and human resources traditionally required for their RandD. Saving millions dollars, POMICELLs automatic and adaptive system helps its partners expedite their decision-making, implement best practices, answer questions, and achieve much faster breakthroughs in their clinical trials and drug discovery and development.
Founders (1)
| Name | Title | Contact | |
|---|---|---|---|
 | ㅤBoaz Buchandler | CEO |
Board and Advisors (0)
Funding Rounds (1)
| Round | Date Announced | Investors | |
|---|---|---|---|
 | ㅤPomicell raises $0.3 million series Seed | July 31, 2018 |
M&A Events (0)
Investors (1)
| Investor Name | Investor Type | AUM ($) | |
|---|---|---|---|
| ㅤGil Tal | Angel | 0 |
Patents (0)
Research Publications (0)
Certifications (0)
AI Technology Stack
4
What makes POMICELL’s AI-powered machine learning system unique is it’s methodologies and approach. We tailor a fast, personal, and cost-effective computational solution to biotech companies’ specific research needs. Our ever-augmenting multilayered metadata space, together with our automatic tools, makes every relevant piece of life-science information readily available and usable for our partners. POMICELL’s agile and adaptive technology doesn’t replace human researchers. Instead, it multiplies the human abilities, and mimics how researchers generate ideas and think. Automating the process, Pomicell draws clear, personally customized drug development road-maps navigating it’s partners through the metadata space toward achieving their RandD goals
News
Jobs (0)